Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes 56:107-112, 2007
DOI: 10.2337/db06-0623
© 2007 by the American Diabetes Association
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, E. Y.
Right arrow Articles by Persson, A. E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, E. Y.
Right arrow Articles by Persson, A. E. G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vascular Reactivity in Arterioles From Normal and Alloxan-Diabetic Mice

Studies on Single Perfused Islets

En Yin Lai1, Leif Jansson1, Andreas Patzak1,2, and A. Erik G. Persson1

1 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden
2 Johannes-Müller Institute of Physiology, University Hospital Charité, Humboldt University of Berlin, Berlin, Germany

Address correspondence and reprint requests to Leif Jansson, Department of Medical Cell Biology, Biomedical Centre, Box 571, SE-751 23 Uppsala, Sweden. E-mail: leif.jansson{at}medcellbiol.uu.se


   ABSTRACT
TOP
 ABSTRACT
RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Pancreatic islets possess an autonomous mechanism of blood flow regulation, independent of that of the exocrine pancreas. To study islet vascular regulation without confounding effects of the exocrine blood vessels, we have developed a technique enabling us to isolate single pancreatic islets and then to perfuse them using their endogenous vasculature for distribution of the medium. This made it possible to directly study the vascular reactivity of islet arterioles to different substances. We confirmed that control of islet blood flow is mainly located at the precapillary level. As expected, administration of angiotensin II and L-nitro-arginine methyl ester contracted islet arterioles, whereas nitric oxide and adenosine dilated them. D-glucose, the main insulin secretagogue, had a selective dilating effect on smooth muscle in islet arterioles but not in glomerular afferent arterioles. The response to glucose was amplified in islet arterioles from diabetic animals, indicating enhanced islet blood perfusion in diabetes. This newly developed technique for perfusing isolated pancreatic islets will provide new insights into islet perfusion control and its possible contributions to the pathogenesis of type 2 diabetes.

The morphology of the pancreatic islets is highly complex, with different endocrine cell types arranged around a sinusoidal network of fenestrated capillaries (1,2). The capillaries are of fundamental importance, not only for delivery of oxygen and nutrients to the endocrine cells but also for providing signals from other cells in the body, as well as for transporting the secreted hormones to the systemic circulation. Furthermore, recent studies indicate that islet endothelium may provide signals for islet cell development (3) and replication in adult animals (4,5).

The islets and the exocrine parenchyma of the pancreas usually possess separate arterioles, emanating from intralobular arteries (1,6). The islets receive blood from one to three arterioles, which then branch into capillaries. How this occurs is a matter of some debate. According to one view, the distribution of the different cell types with regard to the blood capillaries is organized so that high local hormone concentrations can either stimulate or suppress the secretion from the "downstream" endocrine cells (7). However, this view has been questioned (rev. in 2). The effluent blood vessels consist of both venules in the periphery of the islets and of an insulo-acinar portal system comprising small vessels connecting the islet capillaries with capillaries in the exocrine parenchyma. The extent of this portal system is species dependent, and, in rodents, it seems as if large islets do not possess such a portal system but empty their capillaries through venules into intralobular veins (8).

Previous studies have demonstrated that islet blood flow is 5–10 times higher than the blood flow of the exocrine pancreas (2,9). This marked difference in blood perfusion is maintained by separate regulatory mechanisms for the blood perfusion of the islets and acini. It is well known that islet blood flow is normally coupled to islet insulin release (2,9), although they can be dissociated (10), and that the association seems to depend on an intact production of nitric oxide (NO) within the islet vasculature (11,12). The islet arterioles also appears to be more sensitive to the effects of angiotensin II than exocrine blood vessels (13). Furthermore, there is a pronounced increase in basal islet blood flow under conditions of impaired glucose tolerance and in manifest type 1 and type 2 diabetes (9,14). The importance of these vascular disturbances for the deterioration of islet endocrine function seen in diabetes is at present unclear. However, an increase in islet blood perfusion will most likely affect the function of endothelial cells in the islet vasculature by increased shear stress (15–17). This may lead to release of factors that will adversely affect the islet endocrine cells.

In light of these considerations, the present study was undertaken to adapt a technique originally developed for perfusion of renal glomeruli (18–20) for use in single isolated pancreatic islets. This would enable us to specifically study the reactivity of islet arteriolar vascular smooth muscle without any confounding factors imposed by blood vessels supplying the exocrine parenchyma. Furthermore, the establishment of such a technique would make it possible to study the blood distribution within single islets.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Male C57BL/6 mice with a body mass of ~25 g were purchased from Scanbur (Sollentuna, Sweden). Some of the animals were injected intravenously with alloxan (160 mg/kg body wt; Sigma-Aldrich, Irvine, U.K.) 5–7 days before the experiments, and only mice with blood glucose concentrations exceeding 15 mmol/l were selected for further experiments. All animals had access to tap water and pelleted food throughout the experiments. All experiments were approved by the local animal ethics committee at Uppsala University.

Isolation and preparation of islets.
Mice were killed by cervical dislocation, and the pancreas was quickly removed and placed in cold (4°C) albumin-enriched (1%) Dulbecco’s minimal enriched medium (Sigma-Aldrich, Stockholm, Sweden). Islets were dissected with their arterioles intact (21) using a modification of a previously described technique for renal glomeruli (18,19). The time for dissection was limited to 60 min, and most of the obtained islets were large (diameters 400–600 µm). Occasionally, we were also able to isolate medium-sized islets (diameter 200–300 µm), especially in alloxan-diabetic mice, where islets were few and small. To evaluate possible effects of islet size on vascular reactivity, we compared the effects of D-glucose (see PROTOCOL 1) in large islets (diameter 500–600 µm) with that of medium-sized islets (diameter ~200–300 µm). Isolation of the medium-sized islets is difficult to achieve, and since we detected no differences in the reactivity, we subsequently used larger islets. The dissection was performed under a stereo microscope at a magnification of 250x by means of sharpened forceps (no. 5; Dumont, LA-Chaux-de-Fonds, Switzerland). The islets, with their attached arterioles, were cut with miniblades and transferred into a chamber on a stage of an inverted microscope. This experimental set-up allows movement and adjustment of concentric holding and perfusion pipettes (Luigs & Neumann, Ratingen, Germany). The perfusion system (Vestavia Scientific, Vestavia Hills, AL) used manually produced pipettes from custom glass tubes (Drummond Scientific, Broomall, PA). A holding pipette was used to keep the islet in place while another holding pipette, into which the ends of the arterioles were aspirated, was put in place. The latter had an aperture of ~30 µm, whereas the inner perfusion pipette, with an aperture of 5 µm, was advanced into the lumen of the blood vessel (Fig. 1A and B).


Figure 1
View larger version (43K):
[in this window]
[in a new window]

  		FIG. 1. A: An isolated pancreatic islet with the arteriole facing upwards. B: The experimental set-up within the perfusion chamber with holding and perfusion pipettes.

 
Isolation and preparation of renal glomeruli was performed as previously described (18,19). To ascertain the vascular reactivity of the preparations, the experiments ended with administration of KCl.

Perfusion of single islets.
The technique used for perfusion of single islets was that used for renal glomeruli, with some modifications (18,19). The perfusion pipette was connected to a manometer and a reservoir containing the perfusion solution (Krebs-Ringer bicarbonate buffer with 10% HEPES and 1% BSA [hereafter referred to as KRBH], various concentrations of D-glucose [5.5 mmol/l, unless otherwise stated], and other substances as described below). The flow was adjusted by pressure measurements, aiming at 40 mmHg throughout the perfusion period. This corresponds to an approximate flow of 40 nl/min. The end magnification (~300x) results from a Nikon X60/1.2 water immersion objective and a projection (x1) on a 0.3-inch chip digital camera (CB-3803S; GKB, Tai-chung, Taiwan). Data were stored on super video home systems video tapes on a video recorder (Panasonic NV-HS830; Matsushita Audio Video GmbHm, Lüneburg, Germany). These video sequences were digitalized using a frame-grabber card (pciGrabber-4plus; Phytec Technologie Holding, Mainz, Germany), and blood vessel diameters were later analyzed using customized software. This experimental set-up allowed us to continuously measure the diameter of the blood vessels and to record changes at a resolution of <0.2 µm.

KRBH, with pH adjusted to 7.4, was also used for the chamber in which the islets were located. However, the concentration of BSA was only 0.1%. All buffers were exposed to air throughout the experiments. Criteria for using an islet arteriole were remaining basal tone, no pronounced vasodilation, and a fast and complete constriction in response to administration of KCl solution (100 mmol/l) or angiotensin II (Ang II; 10–7 mol/l). Arterioles were allowed to recover for 10 min after the test.

In all series of experiments, the images from the last 10 s of each control or treatment period were used for statistical analyses. Only one concentration-response curve, with or without pretreatment with one other drug, was obtained in each of the perfused islets.

Agents used for perfusions.
D-glucose, 3-O-methyl glucose, Ang II, adenosine, and L-nitro-arginine methyl ester (L-NAME) were purchased from Sigma-Aldrich, and spermine NONO-ate was obtained from VWR International (Stockholm, Sweden).

Perfusion protocols for islets and glomeruli.
Each experiment began with a 15-min equilibrium period with buffer containing 5.5 mmol/l glucose in both the bath and perfusion solution. Thereafter, one of the different test substances was added to the perfusion chamber (all protocols) and/or the perfusion solution (protocols 1 and 2) for 15–30 min.

Islets were subjected to one of the following protocols after the equilibrium period, whereas renal glomeruli were exposed to one of the protocols (1, 2, or 4): 1) 15 min with 17 mmol/l D-glucose (performed separately on large [diameter 500 µm] and medium-sized [diameter 200–300 µm] islets), 2) 15 min with 5.5 mmol/l D-glucose plus 11.5 mmol/l 3-O-methyl glucose, 3) 15 min with adenosine (10–5 mol/l), 4) 14 min with Ang II (2 min with each concentration [10–6 to 10–12 mol/l], beginning with the lowest), and 5) 15 min with L-NAME (10–4 mol/l) or L-NAME plus spermine NONO-ate (5 x 10–4 mol/l).

Each islet/glomerulus was exposed to one of the test substances, and the experiment was then terminated by administration of KCl (100 mmol/l) or Ang II (10–7 mol/l) to ascertain that the arterioles were able to contract. The islet was then fixed in 4% (wt/vol) formaldehyde for 4 h, dehydrated, and embedded in paraffin. Sections 7-µm thick were mounted and stained with hematoxylin and eosin or antibodies against insulin (22).

Statistical calculations.
All values are given as means ± SE. Numbers of observations (n) represent numbers of observed islets, and usually only one islet was isolated per animal. Probabilities (P) of chance differences were calculated with Student’s unpaired t test or ANOVA with Sigmastat (SSSPD, Erkrath, Germany).


   RESULTS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Isolation of islets and glomeruli.
We were able to consistently microdissect islets from both normoglycemic and alloxan-diabetic mice. For obvious technical reasons, it was much easier to locate and prepare large islets (Fig. 1A). In each pancreas of normal mice, there were a few very large islets with diameters between 400 and 600 µm, and the diameters of the arterioles supplying these islets were 30–50 µm. We were occasionally able to isolate medium-sized islets, with a diameter of 200–300 µm, but this was tedious and the success rate low. The identity of these structures as islets was verified by insulin staining of paraffin sections. The islets chosen for the experiments contained one arteriole, and it was rare among these large islets to encounter one with multiple arterioles. The veins were difficult to identify, but we sometimes saw accumulations of erythrocytes at the periphery of the islets immediately after isolation (Fig. 2A). After initiating the perfusion, we could see erythrocytes escaping from some locations along the islet periphery (Fig. 2B), presumably representing cut venules.


Figure 2
View larger version (41K):
[in this window]
[in a new window]

  		FIG. 2. A: An isolated pancreatic islet with an arteriole attached to an intralobular pancreatic artery (bottom). Note the accumulation of erythrocytes especially in the lower periphery of the islet. B: Confocal image of the branching of capillaries in the islet. C: Erythrocytes escaping from a cut venule at the periphery of an islet.

 
The identity of the cannulated microvessels as arterioles was verified by the presence of a single layer of vascular smooth muscle in the media (Fig. 3), which reacted with contraction to administration of Ang II (~20% decrease in diameter) (Fig. 3B) and KCl (almost 90% constriction) (Figs. 3C–D).


Figure 3
View larger version (89K):
[in this window]
[in a new window]

  		FIG. 3. Micrographs of islet arterioles. VMCs are indicated by arrows. A: A control arteriole perfused with buffer. B: Shows constriction in the same arteriole after administration of angiotensin II (10–7 mol/l). An arteriole is also shown both 10 (C) and 30 (D) s after administration of 100 mmol/l KCl.

 
In most islets studied, the arteriole entering the islets branched into smaller tributaries almost immediately after entry into the islet (Fig. 2B). If this occurred in a discontinuity, the non–ß-cell mantle of the islets could not be determined with the present technique. We were unable to determine whether some of the arterioles penetrated into the center of an islet before branching, but we cannot exclude that this may have occurred. We also found that smaller microvessels advanced from the branching arteriole into the central parts or the periphery of the islets. In alloxan-diabetic animals (duration of hyperglycemia 4–7 days), the number of visible islets was much smaller, but occasional islets with a diameter of 200–300 µm were found. Morphologically, these contained some ß-cells, but, as expected, other endocrine cells predominated. Isolated renal glomeruli were smaller than islets and had a diameter of ~100 µm, with afferent arterioles with a size of 8–12 µm.

D-glucose and 3-O-methyl glucose.
The diameter of the renal afferent arterioles did not change when the glucose concentration of the perfusion medium was increased from 5.5 to 17 mmol/l (Figs. 4 and 5). Islet arterioles, on the other hand, displayed a 5% vasodilation in response to an increase in glucose concentration. This response was similar in islets with a diameter of 400–600 µm to that of islets with a diameter of 200–300 µm. There was an even more pronounced dilation of ~10% in islets isolated from diabetic animals. A combination of D-glucose (5.5 mmol/l) and 3-O-methyl glucose (11.5 mmol/l), given the same osmolarity, did not influence either renal or islet arterioles derived from normo- or hyperglycemic mice.


Figure 4
View larger version (17K):
[in this window]
[in a new window]

  		FIG. 4. Changes in the diameters of glomerular afferent arterioles and islet arterioles isolated from normoglycemic and hyperglycemic mice after administration of buffer containing 5.5 or 17 mmol/l D-glucose. Values for islets isolated from normoglycemic animals are given separately for large islets (diameter 500 µm) and medium-sized islets (200–300 µm). Values are given in percent of the diameter before administration of glucose (original diameter ~30 µm) in six to eight animals. *P < 0.05 for comparison with the corresponding values in the other groups; #P < 0.05 compared with islet arterioles from large and medium-sized islets (ANOVA).

 

Figure 5
View larger version (15K):
[in this window]
[in a new window]

  		FIG. 5. Change in the diameter of islet arterioles isolated from normoglycemic mice after administration of buffer containing 5.5 mmol/l D-glucose or 5.5 mmol/l D-glucose plus 11.5 mmol/l 3-O-methyl glucose. Note that the left panel is similar to that in Fig. 4. Values are given in percent of the diameter before administration of glucose (original diameter ~40 µm) in seven animals.

 
Adenosine.
Administration of adenosine caused a 5% dilation of the arterioles in all examined animals (Fig. 6). The response was statistically significant (P < 0.05) at 12 and 15 min after initiation of stimulation.


Figure 6
View larger version (8K):
[in this window]
[in a new window]

  		FIG. 6. Change in the diameter of islet arterioles isolated from normoglycemic mice after administration of buffer containing adenosine (10–5 mol/l). Values are given in percent of diameter before administration of glucose (original diameter ~35 µm) in eight animals. *P < 0.05 compared with the value at time 0 (Student’s t test).

 
Ang II.
As expected, Ang II caused a pronounced dose-dependent constriction of glomerular afferent arterioles, with a maximum constriction of 40% at the highest dose (i.e., 10–6 mol/l) (Fig. 7). Islet arterioles also exhibited dose-dependent constriction but only responded to higher concentrations of Ang II. Furthermore, the maximal vasoconstriction attained was 20%. Islet arterioles prepared from normoglycemic and diabetic animals did not differ in this respect.


Figure 7
View larger version (15K):
[in this window]
[in a new window]

  		FIG. 7. Changes in the diameters of glomerular afferent arterioles and islet arterioles isolated from normoglycemic or hyperglycemic mice after administration of buffer containing different doses of angiotensin II (10–12 to 10–6 mol/l). Values are given in percent of the diameter before administration of glucose (original diameter ~40 µm) in six to eight animals. *P < 0.05, **P < 0.01, and ***P < 0.001 compared with the value at time 0 (Student’s t test).

 
L-NAME and L-NAME plus spermine NONO-ate.
L-NAME alone caused a significant constriction of islet arterioles from normoglycemic mice, which occurred between 6 and 15 min after the start of administration (Fig. 8). The maximal constriction was seen at 15 min and amounted to ~8%.


Figure 8
View larger version (15K):
[in this window]
[in a new window]

  		FIG. 8. Change in arteriolar diameter in islet arterioles isolated from normo- or hyperglycemic mice after administration of buffer containing L-NAME (10–4 mol/l) or L-NAME (10–4 mol/l) plus spermine NONO-ate (5 x 10–4 mol/l). Values are given in percent of the diameter before administration of glucose (original diameter ~35 µm) in 5–14 animals. *P < 0.05, **P < 0.01 compared with the value at time 0 (Student’s t test).

 
Combined administration of L-NAME and spermine NONO-ate caused a progressive vasodilation that began immediately after initiation of the drug administration and reached a plateau after 10–15 min (Fig. 8).


   DISCUSSION
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
This study presents, for the first time, a technique that enables isolation of single pancreatic islets and their perfusion through the endogenous vasculature of the islet. This means that administered substances reach the islets through arterioles and may affect not only the endocrine cells within the islets but also endothelial and vascular smooth muscle cells (VSMs) in the microvessels. As shown, this allowed us to directly study vascular reactivity in islet arterioles without confounding the effects imposed by surrounding exocrine tissues or simultaneous vascular effects induced in exocrine blood vessels. Previous studies (23) have suggested that the control of islet blood flow is mainly precapillary, and this was supported by the vascular response to vasoactive drugs seen in the present study. Our major finding is that D-glucose, the main insulin secretagogue, had a selective dilating effect on VSM in islet arterioles but not in glomerular afferent arterioles. Furthermore, the response to glucose was amplified in islet arterioles in diabetic animals. This is in line with the previous observation of enhanced islet blood perfusion in animals with impaired glucose tolerance or overt type 2 diabetes (9), and the effect may contribute to impaired islet function as outlined further below.

One possible disadvantage of the present technique is that it does not enable us to study all islets (i.e., the whole islet organ) simultaneously as is done with whole-pancreas perfusions. It may be argued that islets are heterogeneous (24) and that the large islets we study are not representative of the average pancreatic islet. In previous studies, it has been demonstrated that small islets, which contribute little to the total pancreatic islet volume (25), do not possess an autonomous vasculature but are incorporated into the exocrine capillary network (1). It seems as if larger islets, which contain most of the endocrine cells (25), receive a major part of the islet blood perfusion (26). Furthermore, there appears to be a subset of islets that, during short-term (30 min) studies, are preferentially perfused (27); however, whether this is also reflected in long-term experiments is not known. It was recently suggested (28) that small rat islets (diameter <125 µm) were functionally superior to larger islets both in vitro and in transplantation outcomes, probably at least partially due to the fact that they are subjected to less ischemia in vitro due to their small size. In view of this, we performed separate studies on islets of two sizes (diameter of 400–600 or 200–300 µm). No differences in the response to glucose was noted, which argues in favor of the notion that the larger islets are representative of the islet organ as a whole. However, the islets referred to as small islets, i.e., a diameter <125 µm by MacGregor et al. (28), are impossible to isolate with the present technique, since they cannot with certainty be distinguished from small groups of exocrine acini. In the present study, we usually chose one islet per pancreas, and this islet was usually very large with a diameter of 400–600 µm. The number of such islets per pancreas was small, usually around three to five. In some normoglycemic animals and in most alloxan-diabetic mice, we could also isolate medium-sized islets, with a diameter of 200–300 µm. All isolated islets reacted similarly to the applied vasoactive drugs, irrespective of size. We therefore consider that the islets we have studied are representative of the islet endocrine organ as a whole and that we can draw conclusions about islets in general from our findings.

Of major interest, as mentioned above, was our finding that D-glucose dilated islet arterioles but not glomerular afferent arterioles. That this effect was specific for D-glucose was verified by the finding that the nonmetabolizable glucose analog 3-O-methyl glucose, which served as an osmotic control, had no effects. The time schedule for the effect of D-glucose was similar to that of adenosine, i.e., it was seen after ~10 min. This is of considerable interest, since we know from previous studies (29) that the initial islet hyperemia in response to increased glucose concentrations is mainly mediated through the vagus nerve. However, starting ~10 min after D-glucose administration, and continuing for an additional 15 min, the increased glucose metabolism within the islets produces and releases adenosine (30), which has been shown to be responsible for this later hyperemia (31). Thus, the present findings verify the in vivo observations and suggest that the released adenosine has a direct effect on the islet microcirculation. This may be caused by adenosine affecting arteriolar VSMs where the vessel penetrates into the islet and subsequent propagation of this signal through gap junctions. This emphasizes the complexity of the control mechanisms for islet blood perfusion and suggests the importance of these mechanisms for normal homeostasis.

Of even more interest in this context was the finding that arteriolar dilation in response to D-glucose was enhanced in islets derived from diabetic animals. This points to another mechanism, besides the already suggested central nervous effects of D-glucose (29,32), to explain the islet hyperperfusion of blood seen in animal models of type 2 diabetes and impaired glucose tolerance (9,14), namely that hyperglycemia may cause direct local dilation of islet arterioles. In view of the possible deleterious effects of increased blood flow caused by increased shear stress and the release of potentially harmful endothelial mediators (15–17), this is of interest. Whether the flow increase is due to increased glucose metabolism (i.e., adenosine), increased glucagon secretion from islets in diabetic animals (glucagon is a vasodilator [33]), increased production of local NO (11), or any other local factor remains to be determined. It should also be noted that both type 1 (34) and type 2 diabetes can be associated with local inflammatory reactions (35,36), which may also lead to an increased propensity for vascular dilation. It should also be noted that there are other cells present at the vascular pole of the islet, such as macrophages and adipocytes, the products of which may also influence arteriolar reactivity.

The finding that administration of L-NAME constricted islet arterioles, whereas spermine NONO-ate dilated them, confirms previous observations in vivo (11,12). Of interest in this context is that NO dilated the islet arteriole under normo- and hyperglycemic conditions. The present results, together with previous observations (37,38), suggest that NO is indeed involved in the regulation of the basal tone in islet arterioles. We have previously proposed that an intact NO production is a prerequisite for high basal islet blood perfusion, but the present findings suggest that not all of the NO effects are elicited through arteriolar dilation by a direct action on VSM. Thus, the decrease in diameter by only 8% on administration of L-NAME can theoretically— according to Poiseuille’s law, which states that the flow is proportional to the fourth power of the radius—diminish flow by 30%; however, findings in vivo suggest that the blood flow is decreased by several hundred percent (12). There is an increase of similar magnitude when NO is administered exogenously. This suggests that other, as yet unknown, effects of NO, besides its effects on VSM, are also involved in the NO dependency of the high basal islet blood perfusion. One possibility could be dilating effects on pericytes (39), but such cells are very sparse in normal islets (40), although they can be seen in islet tumorigenesis (41).

The constrictive effects of Ang II on islet arterioles were concentration dependent and very pronounced at higher concentrations. This is in accordance with the previous observation in vivo of a pronounced sensitivity of islet arterioles to this substance (13). Furthermore, we previously noted that inhibition of ACE increased islet blood flow in healthy rats (13).

The present technique also confirms previous observations on islet vascular anatomy (1,6). It should be kept in mind that we have mainly studied very large islets, and we have consistently noted that the arteriole branches at the periphery of the islet. This is in contrast to other reports suggesting that the distribution of the different cell types, with regard to the blood capillaries, is organized so that the arterial blood first reaches the ß-cells, then the {alpha}-cell, and then the {delta}-cells (42). In the latter model, it is presumed that the arterioles penetrates into the center of the islets, i.e., to the ß-cell–rich core, before branching into capillaries that then radiate toward the periphery of the islets. This direction of the blood flow has been claimed to be essential for normal islet function, since the high local hormone concentrations can either stimulate or suppress the secretion of the downstream endocrine cells (42). Other theories have also been proposed, and the issue is at the moment under debate (2). However, the present study shows that this is not the case for very large islets, but we are unable to determine what happens in smaller islets.


   ACKNOWLEDGMENTS
 
The study was supported by a generous Innovative Grant from the Juvenile Diabetes Research Foundation International and partially by grants from the Swedish Research Council (72X-109 and 04-03522-32), the Swedish Heart and Lung Foundation (20040645), the Wallenberg Foundation, the NOVO Nordic Fund, and the Ingabritt and Arne Lundberg Foundation.


   FOOTNOTES
 
Ang II, angiotensin II; L-NAME, L-nitro-arginine methyl ester; VSM, vascular smooth muscle cell.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received for publication May 5, 2006 and accepted in revised form October 13, 2006


   REFERENCES
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Bonner-Weir S: The microvasculature of the pancreas, with emphasis on that of the islets of Langerhans: anatomy and functional implications. In The Pancreas. Biology, Pathobiology, and Disease. 2nd ed. Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, Eds. New York, Raven Press, 1993, p.759–768
  2. Brunicardi FC, Stagner J, Bonner-Weir S, Wayland H, Kleinman R, Livingston E, Guth P, Menger M, McCuskey R, Intaglietta M, Charles A, Ashley S, Cheung A, Ipp E, Gilman S, Howard T, Passaro E Jr: Microcirculation of the islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes 45:385–392, 1996[Medline]
  3. Lammert E, Cleaver O, Melton D: Induction of pancreatic differentiation by signals from blood vessels. Science 294:564–567, 2001[Abstract/Free Full Text]
  4. Johansson M, Mattsson G, Andersson A, Jansson L, Carlsson PO: Islet endothelial cells and pancreatic ß-cell proliferation: atudeis in vitro and during pregnancy in adult rats. Endocrinology 147:2315–2324, 2006[Abstract/Free Full Text]
  5. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L, Fassler R, Gu G, Gerber HP, Ferrara N, Melton DA, Lammert E: The vascular basement membrane: a niche for insulin gene expression and beta cell proliferation. Dev Cell 10:397–405, 2006[Medline]
  6. Thiel A: [Studies on vascular system of pancreatic lobule in various mammals with special reference to the capillary glomeruli of Islands of Langerhans]. Z Zellforsch Mikrosk Anat 39:339–372, 1954 (article in German)[Medline]
  7. Samols E, Stagner JI, Ewart RB, Marks V: The order of islet microvascular cellular perfusion is B-A-D in the perfused rat pancreas. J Clin Invest 82:350–353, 1988[Medline]
  8. Henderson JR, Daniel PM, Fraser PA: The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22:158–167, 1981[Free Full Text]
  9. Jansson L: The regulation of pancreatic islet blood flow. Diabetes Metab Rev 10:407–416, 1994[Medline]
  10. Jansson L: Dissociation between pancreatic islet blood flow and insulin release in the rat. Acta Physiol Scand 124:223–228, 1985[Medline]
  11. Moldovan S, Livingston E, Zhang RS, Kleinman R, Guth P, Brunicardi FC: Glucose-induced islet hyperemia is mediated by nitric oxide. Am J Surg 171:16–20, 1996[Medline]
  12. Svensson AM, Östenson CG, Sandler S, Efendic S, Jansson L: Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135:849–853, 1994[Abstract]
  13. Carlsson PO, Berne C, Jansson L: Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia 41:127–133, 1998[Medline]
  14. Atef N, Portha B, Penicaud L: Changes in islet blood flow in rats with NIDDM. Diabetologia 37:677–680, 1994[Medline]
  15. Wasserman SM, Topper JN: Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications. Vasc Med 9:35–45, 2004[Abstract/Free Full Text]
  16. Brooks AR, Lelkes PI, Rubanyi GM: Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis. Endothelium 11:45–57, 2004[Medline]
  17. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, Wofovitz E: Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol 81:177–199, 2003[Medline]
  18. Patzak A, Mrowka R, Storch E, Hocher B, Persson PB: Interaction of angiotensin II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 12:1122–1127, 2001[Abstract/Free Full Text]
  19. Patzak A, Lai EY, Mrowka R, Steege A, Persson PB, Persson AE: AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int 66:1949–1958, 2004[Medline]
  20. Edwards RM: Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244:F526–F534, 1983[Medline]
  21. Hellerstrom C: Effects of carbohydrates on the oxygen consumption of isolated pancreatic islets of mice. Endocrinology 81:105–112, 1967[Medline]
  22. Mattsson G, Danelsson A, Kriz V, Carlsson P-O, Jansson L: Endothelial cells in endogenous and transplanted islets: differences in the expression of angiogenic peptides and receptors. Pancreatology 6:86–95, 2006[Medline]
  23. Carlsson PO, Jansson L, Östenson CG, Källskog Ö: Islet capillary blood pressure increase mediated by hyperglycemia in NIDDM GK rats. Diabetes 46:947–952, 1997[Abstract]
  24. Pipeleers D, Kiekens R, Ling Z, Wilikens A, Schuit F: Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 37 (Suppl. 2):S57–S64, 1994
  25. Hellman B: The volumetric distribution of the pancreatic islet tissue in young and old rats. Acta Endocrinol (Copenh ) 31:91–106, 1959[Medline]
  26. Lifson N, Lassa CV, Dixit PK: Relation between blood flow and morphology in islet organ of rat pancreas. Am J Physiol 249:E43–E48, 1985[Medline]
  27. Jansson L: Microsphere distribution in the pancreas of anesthetized rats. Alloxan stimulates the blood flow to all islets whereas glucose only affects the blood perfusion of a subgroup of islets. Int J Pancreatol 20:69–74, 1996[Medline]
  28. MacGregor RR, Williams SJ, Tong PY, Kover K, Moore WV, Stehno-Bittel L: Small rat islets are superior to large islets in in vitro function and in transplantation outcomes. Am J Physiol Endocrinol Metab 290:E771–E779, 2006[Abstract/Free Full Text]
  29. Jansson L, Hellerström C: Glucose-induced changes in pancreatic islet blood flow mediated by central nervous system. Am J Physiol 251:E644–E647, 1986[Medline]
  30. Welsh M, Andersson A: Adenosine uptake by isolated mouse pancreatic islets. Biochem Pharmacol 30:2075–2080, 1981[Medline]
  31. Carlsson PO, Olsson R, Källskog Ö, Bodin B, Andersson A, Jansson L: Glucose-induced islet blood flow increase in rats: interaction between nervous and metabolic mediators. Am J Physiol Endocrinol Metab 283:E457–E464, 2002[Abstract/Free Full Text]
  32. Atef N, Ktorza A, Picon L, Penicaud L: Increased islet blood flow in obese rats: role of the autonomic nervous system. Am J Physiol 262:E736–E740, 1992[Medline]
  33. Farah AE: Glucagon and the circulation. Pharmacol Rev 35:181–217, 1983[Abstract]
  34. Kolb H: Benign versus destructive insulitis. Diabetes Metab Rev 13:139–146, 1997[Medline]
  35. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, Reinecke M: Mechanisms of ß-cell death in type 2 diabetes. Diabetes 54 (Suppl. 2):S108–S113, 2005
  36. Kolb H, Mandrup-Poulsen T: An immune origin of type 2 diabetes? Diabetologia 48:1038–1050, 2005[Medline]
  37. Jansson L, Andersson A: Nitric oxide and pancreatic islet blood flow after induced portal hypertension in rats. Pancreas 14:280–284, 1997[Medline]
  38. Svensson AM, Sandler S, Jansson L: The blood flow in pancreatico-duodenal grafts in rats: inhibition of nitric oxide synthase preferentially decreases islet blood flow. Eur J Pharmacol 275:99–103, 1995[Medline]
  39. Pallone TL, Silldorff EP: Pericyte regulation of renal medullary blood flow. Exp Nephrol 9:165–170, 2001[Medline]
  40. Lukinius A, Jansson L, Korsgren O: Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol 146:429–435, 1995[Abstract]
  41. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D: Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 4:393–403, 2003[Medline]
  42. Stagner JI, Samols E: The vascular order of islet cellular perfusion in the human pancreas. Diabetes 41:93–97, 1992[Abstract]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
Z. H. Nemeth, D. Bleich, B. Csoka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabo, B. N. Cronstein, et al.
Adenosine receptor activation ameliorates type 1 diabetes
FASEB J, August 1, 2007; 21(10): 2379 - 2388.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
E. Y. Lai, A. E. G. Persson, B. Bodin, O. Kallskog, A. Andersson, U. Pettersson, P. Hansell, and L. Jansson
Endothelin-1 and pancreatic islet vasculature: studies in vivo and on isolated, vascularly perfused pancreatic islets
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1616 - E1623.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, E. Y.
Right arrow Articles by Persson, A. E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, E. Y.
Right arrow Articles by Persson, A. E. G.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum